Beyond Biomimetics: Pathology‐Informed Engineering Rescues Reconstituted HDL From Inflammatory Dysfunction for Sepsis Immunotherapy
Authors:
Open Access
- 10 September 2026
- journal article
- Published by Wiley in Advanced Science
- p. e77714
Abstract
Biomimetic therapies hold great promise for treating intractable diseases, yet their translation is often hindered by dysfunction—the loss of intended biological function upon exposure to pathological microenvironments. This challenge is well exemplified by reconstituted high‐density lipoprotein (rHDL), a clinically advanced HDL mimetic and representative biomimetic drug delivery platform. Here, guided by a pathology‐informed identification‐design‐evaluation‐validation workflow, we identified representative sepsis‐relevant dysfunction liabilities of HDL‐based systems under pathology‐relevant conditions and designed an adaptive engineered guard for inflammatory stress (AEGIS) strategy to rescue rHDL function. AEGIS integrates triphenylphosphine‐modified ceria nanozyme‐celastrol coordination complex (TCe–C) into rHDL to form TCe‐C@rHDL, enabling carrier protection, decoupling disease‐driven damage from dysfunction, and preserving HDL‐intrinsic routing for hierarchical cytoplasmic and mitochondrial delivery. Across multiple evaluation models, including inflammatory biochemical challenges, patient serum under shear flow, and inflammatory animal settings, TCe‐C@rHDL consistently preserved biomimetic function better than a clinical‐stage CER‐001 mimetic. This performance was further validated by therapeutic efficacy in vivo, restoring 90% survival in LPS‐induced systemic inflammation versus 40% for the CER‐001 mimetic, and improving survival to 80% in the CLP model when combined with antibiotics versus 40% for antibiotics alone. Collectively, this work establishes a paradigm for next‐generation biomimetic systems that remain functional under pathological stress.Keywords
Funding Information
- National Natural Science Foundation of China (82470351)
This publication has 55 references indexed in Scilit:
- NIR Driven Pd/Cerium Oxide Nano‐Heterojunction for Enhanced Salvaging Sepsis Induced Acute Liver Injury via Reprogramming Redox Homeostasis in Synergy with Inducing AutophagyAdvanced Science, 2025
- Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of CelastrolExploration, 2025
- Synthetic Biomimetic Liposomes Harness Efferocytosis Machinery for Highly Efficient Macrophages‐Targeted Drug Delivery to Alleviate InflammationAdvanced Science, 2024
- A Nanodisc‐Paved Biobridge Facilitates Stem Cell Membrane Fusogenicity for Intracerebral Shuttling and Bystander EffectsAdvanced Materials, 2023
- Ceria‐Based Therapeutic Antioxidants for Biomedical ApplicationsAdvanced Materials, 2023
- Oxidative modification of HDL by lipid aldehydes impacts HDL functionArchives of Biochemistry and Biophysics, 2022
- ATP‐Responsive and ATP‐Fueled Self‐Assembling Systems and MaterialsAdvanced Materials, 2020
- Triphenylphosphonium (TPP)‐Based Antioxidants: A New Perspective on Antioxidant DesignChemMedChem, 2020
- Bio‐distribution andin vivoantioxidant effects of cerium oxide nanoparticles in miceEnvironmental Toxicology, 2011
- Biomimetic Nanocarrier for Direct Cytosolic Drug DeliveryAngewandte Chemie International Edition, 2009